Over the past 15 years, notable startups such as Colucid, Endocyte, Assembly Biosciences and Marcadia Biotech have captured national headlines as they were launched and became Indiana’s pharma success stories. These companies and many others have taken center stage at previous BioCrossroads events showcasing the long, risky and capital-intensive road to success.

And the story continues. Last year, Indiana chalked up a record-breaking year for life sciences venture capital investments with $115 million invested in 34 life sciences and HIT startups. At the top of the list is Outpost Medicine, who is developing novel therapeutics for the treatment of urologic and gynecologic disorders. Another company new to Indiana, Acacia Pharma, is focused on the development and commercialization of new nausea treatments for surgical and cancer patients.

In this session, you’ll learn about these companies, the road that led them to Indiana and their future plans.